Basic information Safety Supplier Related

7-BROMO-1H-PYRIDO[2,3-B][1,4]OXAZIN-2(3H)-ONE

Basic information Safety Supplier Related

7-BROMO-1H-PYRIDO[2,3-B][1,4]OXAZIN-2(3H)-ONE Basic information

Product Name:
7-BROMO-1H-PYRIDO[2,3-B][1,4]OXAZIN-2(3H)-ONE
Synonyms:
  • 7-BROMO-1H-PYRIDO[2,3-B][1,4]OXAZIN-2(3H)-ONE
  • 7-BROMO-1H-PYRIDO[2,3-B][1,4]OXAZIN-2-ONE
  • 7-broMo-1H,2H,3H-pyrido[2,3-b][1,4]oxazin-2-one
  • :1H-Pyrido[2,3-b][1,4]oxazin-2(3H)-one,7-broMo
  • 6-bromo-1,2-dihydropyrido[2,3-b][1,4]oxazin-3-one
  • 7-Bromo-1H-pyrrolo [2,3-B] [1,4] oxazine-2 (3H) - one
CAS:
105544-36-3
MF:
C7H5BrN2O2
MW:
229.03
Mol File:
105544-36-3.mol
More
Less

7-BROMO-1H-PYRIDO[2,3-B][1,4]OXAZIN-2(3H)-ONE Chemical Properties

Melting point:
247-251 °C(Solv: ethanol (64-17-5))
Boiling point:
398.8±42.0 °C(Predicted)
Density 
1.772±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
pka
10.67±0.20(Predicted)
form 
solid
InChI
InChI=1S/C7H5BrN2O2/c8-4-1-5-7(9-2-4)12-3-6(11)10-5/h1-2H,3H2,(H,10,11)
InChIKey
UTPFXZJAASMEDW-UHFFFAOYSA-N
SMILES
O1CC(=O)NC2=CC(Br)=CN=C12
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22
WGK Germany 
3
HazardClass 
IRRITANT
More
Less

7-BROMO-1H-PYRIDO[2,3-B][1,4]OXAZIN-2(3H)-ONE Usage And Synthesis

Uses

7-Bromo-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one is an important chemical reagent that can be used to prepare heteroaryl compounds. The synthetic product can effectively inhibit necrosis and thus finds application in the treatment of diseases and conditions related to the necrosis pathway, including, for example, inflammation, tumors, metabolic diseases, and neurodegenerative diseases such as cerebral ischemia and stroke.

Synthesis

7-Bromo-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one is prepared by reacting 6-bromo-1H-pyrrolo[3,2-b]pyridine with pyridine and cyclohexyl carbonochloridate in anhydrous THF solution. The specific reaction process is as follows: To a solution of 6-bromo-1H-pyrrolo[3,2-b]pyridine (97 mg, 0.5 mmol) in anhydrous THF (5 mL) was added slowly pyridine (120 mg, 1.5 mmol) followed by cyclohexyl carbonochloridate (162 mg, 1 mmol) in THF (2 mL). The mixture was stirred at room temperature for 3 h. The reaction was quenched by the addition of saturated NaCl solution (20 mL). The aqueous phase was extracted with EtOAc (3×) and the combined organic layers were combined, dried and concentrated. The residue was purified by silica gel column chromatography (petroleum ether/ethyl acetate = 5/1) to give 7-Bromo-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one as a colorless oily liquid (120 mg, 75%).1H NMR (400 MHz, DMSO-d6) d 8.58 (s, 2H), 7.84 (d, J = 2.4 Hz, 1H), 8.77 (d, J = 3.6 Hz, 1H), 5.13-5.00 (m, 1H), 2.13-1.97 (m, 2H), 1.91-1.75 (m, 2H), 1.72- 1.33 (m, 6H).

7-BROMO-1H-PYRIDO[2,3-B][1,4]OXAZIN-2(3H)-ONESupplier

Shanghai Helai Biotech Co. Ltd. Gold
Tel
15721400568
Email
helaibiotech@163.com
Medsyn Biotechnology Co., Ltd Gold
Tel
028-82250492; 15121117545
Email
viola.liu@medsynbio.cn
Wuhan Chemwish Technology Co., Ltd
Tel
86-027-67849912
Email
sales@chemwish.com
Accela ChemBio Co.,Ltd.
Tel
021-50795510 4000665055
Email
sales@accelachem.com
Shanghai Longsheng chemical Co.,Ltd.
Tel
021-58099652-8005 13585536065
Email
bin.wu@shlschem.com